Precision Oncology Trials: A Look Ahead


Life science sponsors are incorporating patient genetic and genomic information in clinical development programs to find the most accurate and effective treatments for patient populations. However, these approaches require specific subsets of patients, making it more difficult for sponsors to recruit sufficient patients in a timely manner.

View PDF